Biblio

Filters: Author is O'Brien, Timothy [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1

Ismail S, O'Brien T, Barry F. 188 The Cardioprotective Effect of MSC Secreted Protein in an in Vitro Model of Myocardial Injury: the Mechanistic Insight. Heart. 2014;100(Suppl 3):A105.

C

Ding Y, Carvalho E, Murphy C, McInerney V, Krawczyk J, O'Brien T, Howard L, Cai L, Shen S. Corrigendum to "Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)" [Stem Cell Res. (43) 2020 101665]. Stem Cell Res. 2022;63:102850.

D

Ding Y, de la Cruz BMarcó, Xia Y, Liu M, Lu Y, McInerney V, Krawczyk J, Lynch SA, Howard L, O'Brien T, et al. Derivation of familial iPSC lines from three ASD patients carrying NRXN1α and two controls (NUIGi022-A, NUIGi022-B; NUIGi023-A, NUIGi023-B; NUIGi025-A, NUIGi025-B; NUIGi024-A, NUIGi024-B; NUIGi026-A, NUIGi026-B). Stem Cell Res. 2019;41:101653.

Ding Y, Carvalho E, Murphy C, McInerney V, Krawczyk J, O'Brien T, Howard L, Cai L, Shen S. Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A). Stem Cell Res. 2019;43:101665.

Ding Y, O'Brien A, de la Cruz BMarcó, Yang M, Lu Y, Qian X, Yang G, McInerney V, Krawczyk J, Lynch SA, et al. Derivation of four iPSC lines from a male ASD patient carrying a deletion in the middle coding region of NRXN1α gene (NUIGi039-A and NUIGi039-B) and a male sibling control (NUIGi040-A and NUIGi040-B). Stem Cell Res. 2021;53:102254.

Ding Y, O'Brien A, de la Cruz BMarcó, Yang M, Fitzgerald J, Yang G, Li W, McInerney V, Krawczyk J, Lynch SA, et al. Derivation of iPSC lines from two patients with autism spectrum disorder carrying NRXN1α deletion (NUIGi041-A, NUIG041-B; NUIGi045-A) and one sibling control (NUIGi042-A, NUIGi042-B). Stem Cell Res. 2021;52:102222.

de la Cruz BMarcó, Ding Y, McInerney V, Krawczyk J, Lu Y, Yang G, Qian X, Li W, Howard L, Allen NM, et al. Derivation of two iPSC lines from a sporadic ASD patient (NUIGi033-A) and a paternal control (NUIGi034-A). Stem Cell Res. 2020;44:101722.

Leszczynska A, O'Doherty A, Farrell E, Pindjakova J, O'Brien FJ, O'Brien T, Barry F, J Murphy M. Differentiation of Vascular Stem Cells Contributes to Ectopic Calcification of Atherosclerotic Plaque. Stem Cells. 2016.

G

Ma J, Guo R, Song Y, Zhang J, Feng B, Amponsah AErnest, Kong D, He J, Zhang W, Liu A, et al. Generation and characterization of a human induced pluripotent stem cell (iPSC) line (HEBHMUi001-A) from a sporadic Parkinson's disease patient. Stem Cell Res. 2019;36:101417.

Ge N, Liu M, Krawczyk J, McInerney V, Ward D, Shen S, O'Brien T, Prendiville T. Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant. Stem Cell Res. 2020;49:101997.

Liu M, Ge N, Han Y, Reilly J, Yang M, Yang F, Krawczyk J, McInerney V, O'Brien T, Prendiville T, et al. Generation and characterization of three induced pluripotent stem cell lines (NUIGi046-A, NUIGi046-B, NUIGi046-C) from a 51-year-old healthy individual. Stem Cell Res. 2021;57:102607.

Ge N, Liu M, Ding Y, Krawczyk J, McInerney V, Galvin J, Shen S, Prendiville T, O'Brien T. Generation and characterization of twelve human induced pluripotent stem cell (iPSC) lines from four familial long QT syndrome type 1 (LQT1) patients carrying KCNQ1 c.1201dupC mutation. Stem Cell Res. 2019;41:101650.

Ge N, Liu M, Zhu X, Krawczyk J, McInerney V, Shen S, O'Brien T, Prendiville T. Generation and characterization of two induced pluripotent stem cell lines (NUIGi038-A, NUIGi038-B) from dermal fibroblasts of a healthy individual. Stem Cell Res. 2020;49:101996.

Ge N, Liu M, Krawczyk J, McInerney V, Galvin J, Shen S, O'Brien T, Prendiville T. Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-. Stem Cell Res. 2019;39:101502.

Yang M, Liu M, Vajda A, O'Brien T, Henshall D, Hardiman O, Shen S. Generation of six induced pluripotent stem cell (iPSC) lines from two patients with amyotrophic lateral sclerosis (NUIGi043-A, NUIGi043-B, NUIGi043-C, NUIGi044-A, NUIGi044-B, NUIGi044-C). Stem Cell Res. 2019;40:101558.

Stewart R, Gadoud C, Krawczyk J, McInerney V, O'Brien T, Shen S, Allen NM. Generation of three induced pluripotent stem cell lines from a patient with KCNQ2 developmental and epileptic encephalopathy as a result of the pathogenic variant c.638C > T; p.Arg213Gln (NUIGi063-A, NUIGi063-B, NUIGi063-C) and 3 healthy controls (NUIGi. Stem Cell Res. 2023;69:103093.

Stewart R, Gadoud C, Krawczyk J, McInerney V, O'Brien T, Shen S, Allen NM. Generation of three induced pluripotent stem cell lines from a patient with KCNQ2 developmental and epileptic encephalopathy as a result of the pathogenic variant c.881C > T; p.Ala294Val (NUIGi059-A, NUIGi059-B, NUIGi059-C) and 3 healthy controls (NUIGi. Stem Cell Res. 2023;71:103191.

Yang M, Liu M, Ding Y, Vajda A, Ma J, Cui H, O'Brien T, Henshall D, Hardiman O, Shen S. Generation of twelve induced pluripotent stem cell lines from two healthy controls and two patients with sporadic amyotrophic lateral sclerosis. Stem Cell Res. 2020;44:101752.

I

Sanz-Nogués C, O'Brien T. In vitro models for assessing therapeutic angiogenesis. Drug Discov Today. 2016.

Avazzadeh S, McDonagh K, Reilly J, Wang Y, Boomkamp SD, McInerney V, Krawczyk J, Fitzgerald J, Feerick N, O'Sullivan M, et al. Increased Ca signaling in neurons derived from ASD induced pluripotent stem cells. Mol Autism. 2019;10:52.

Feng B, Ma J, Amponsah AErnest, Guo R, Kong D, He J, Jiang Y, Zhang W, Zhang Z, Song Y, et al. Induced pluripotent stem cell line derived from a sporadic amyotrophic lateral sclerosis patient. Stem Cell Res. 2020;45:101841.

M

Faria J, Calcat-I-Cervera S, Skovronova R, Broeksma BC, Berends AJ, Zaal EA, Bussolati B, O'Brien T, Mihaila SM, Masereeuw R. Mesenchymal stromal cells secretome restores bioenergetic and redox homeostasis in human proximal tubule cells after ischemic injury. Stem Cell Res Ther. 2023;14(1):353.

P

Liu B, Zhang J, Zhou Z, Feng B, He J, Yan W, Zhou X, Amponsah AErnest, Guo R, Du X, et al. Preclinical Evidence for the Effectiveness of Mesenchymal Stromal Cells for Diabetic Cardiomyopathy: A Systematic Review and Meta-Analysis. Curr Stem Cell Res Ther. 2023.

S

Ahmed N, Li L, Rojas P, Covut F, Reese-Koc J, Kolk M, Malek E, Metheny L, O'Brien T, Caimi P, et al. Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria. Bone Marrow Transplant. 2021.

T

Hayes M, Masterson C, Devaney J, Barry F, Elliman S, O'Brien T, Toole DO', Curley GF, Laffey JG. Therapeutic Efficacy of Human Mesenchymal Stromal Cells in the Repair of Established Ventilator-induced Lung Injury in the Rat. Anesthesiology. 2014.

Pages